FE 200486
Drug timelines are a Plus or Pro feature.
1 regulatory and trial event tracked for FE 200486, covering 2009-03-31 to 2009-03-31. Get the full timeline:
Most recent: Clinical Trial Update: The Efficacy and Safety of FE 200486 in Treatment of Patients Suffering From Prostate Cancer [Phase 2]